A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : KRAS / KRAS proto-oncogene, GTPase

[Related PubMed/MEDLINE]
Total Number of Papers: 25
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   KRAS  (>> Co-occurring Abbreviation)
Long Form:   KRAS proto-oncogene, GTPase
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Exosomal Circ-MEMO1 Promotes the Progression and Aerobic Glycolysis of Non-small Cell Lung Cancer Through Targeting MiR-101-3p/KRAS Axis. 3'UTR, circ-MEMO1, exo-circ-MEMO1, GM130, HK2, LDHA, miR-101-3p, mRNA, NSCLC, qRT-PCR, RIP
2020 Mediastinal Germ Cell Tumor and Acute Megakaryoblastic Leukemia With Co-occurring KRAS Mutation and Complex Cytogenetics. AMKL, NSGCTs, PTEN, TP53
2020 Upregulation of microRNA-31 is associated with poor prognosis in patients with advanced colorectal cancer. BRAF, CRC, MSI, MST
2019 Different mutation profiles between epithelium and stroma in endometriosis and normal endometrium. PIK3CA
2019 Downregulation of miR‑143 modulates KRAS expression in colorectal carcinoma cells. miRs
2019 Expression and role of EGFR, cyclin D1 and KRAS in laryngocarcinoma tissues. EGFR
2019 Molecular mutation characteristics of mismatch and homologous recombination repair genes in gastrointestinal cancer. APC, ATM, BRCA1, BRCA2, ERBB2, HR, MMR, PMS2, SNVs, TP53
2019 Phenotypic characterization of the novel, non-hotspot oncogenic KRAS mutants E31D and E63K. EGFR
2019 Prognostic value of KRAS/TP53/PIK3CA in non-small cell lung cancer. NSCLC, PFS, PIK3CA, TP53
10  2019 Transformation to small cell lung cancer and activation of KRAS during long-term erlotinib maintenance in a patient with non-small cell lung cancer: A case report. EGFR, non-SCLC, TKIs
11  2018 Genome-wide transcriptional analysis of BRD4-regulated genes and pathways in human glioma U251 cells. BRD4
12  2018 Overexpression of MTH1 and OGG1 proteins in ulcerative colitis-associated carcinogenesis. IDH1, iNOS, MTH1, MUTYH, TP53, UC
13  2018 Primary Liver Cancers, Part 2: Progression Pathways and Carcinogenesis. HCC, ICC, NRAS
14  2018 The clinical significance of COL5A2 in patients with bladder cancer: A retrospective analysis of bladder cancer gene expression data. ---
15  2017 A case report of tongue metastasis from lung squamous cell carcinoma and literature review. PIK3CA, TP53
16  2017 All for one and FOSL1 for all: FOSL1 at the crossroads of lung and pancreatic cancer driven by mutant KRAS. FOSL1
17  2017 Coffee reduces KRAS expression in Caco-2 human colon carcinoma cells via regulation of miRNAs. miR
18  2017 Colorectal cancer in cases of multiple primary cancers: Clinical features of 59 cases and point mutation analyses. CRC, MPCC
19  2017 Diagnostic and prognostic value of blood samples for KRAS mutation identification in lung cancer: a meta-analysis. 1- sensitivity, AUC, ctDNA, DOR, FN, FP, NLR, PLR, TN, TP
20  2017 Screening of mutations in the additional sex combs like 1, transcriptional regulator, tumor protein p53, and KRAS proto-oncogene, GTPase/NRAS proto-oncogene, GTPase genes of patients with myelodysplastic syndrome. ASXL1, MDS, NRAS, TP53
21  2017 Unique presentation of cutis laxa with Leigh-like syndrome due to ECHS1 deficiency. BRAF, ECHS1, HRAS, IEM, MACS, MAP, NRAS, PTPN11, RAF1, RIN2, SOS2, TALDO1
22  2017 Wild‑type blocking pcr coupled with internal competitive amplified fragment improved the detection of rare mutation of KRAS. WTB
23  2016 KRAS mutations in the circulating free DNA (cfDNA) of non-small cell lung cancer (NSCLC) patients. cfDNA, NSCLC, OS, PFS
24  2016 Low mutation percentage of KRAS and BRAF genes in Brazilian anal tumors. BRAF, HPV, HSIL, SCC
25  2016 Role of specific DNA mutations in the peripheral blood of colorectal cancer patients for the assessment of tumor stage and residual disease following tumor resection. BRAF, CRC